AAGH (America Great Health) Net Margin %: 2,473.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is America Great Health Net Margin %?

America Great Health AAGH Net Margin % is 2,473.33% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 942 Biotechnology companies, America Great Health ranks better than 98.41% on this metric.

Net margin is calculated as Net Income divided by its Revenue. America Great Health's Net Income for the three months ended in Dec. 2025 was $1.11 Mil. America Great Health's Revenue for the three months ended in Dec. 2025 was $0.05 Mil. Therefore, America Great Health's net margin for the quarter that ended in Dec. 2025 was 2,473.33%.

The historical rank and industry rank for America Great Health's Net Margin % or its related term are showing as below:

AAGH' s Net Margin % Range Over the Past 10 Years
Min: -4634.29   Med: -393.47   Max: 164.47
Current: 164.47


AAGH's Net Margin % is ranked better than
98.41% of 942 companies
in the Biotechnology industry
Industry Median: -89.445 vs AAGH: 164.47

America Great Health  (OTCPK:AAGH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


America Great Health Net Margin % Related Terms


America Great Health Net Margin % Historical Data

* Premium members only.

The historical data trend for America Great Health's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

America Great Health Net Margin % Chart

America Great Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -137.24 -4,634.29 -373.04 -413.90 -183.42

America Great Health Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -212.09 -282.14 -211.43 -45.21 2,473.33

AAGH vs ADTX, PKTX, BBLG: Net Margin % Comparison

For the Biotechnology subindustry, America Great Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


America Great Health Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, America Great Health's Net Margin % distribution charts can be found below:

* The bar in red indicates where America Great Health's Net Margin % falls into.



America Great Health Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

America Great Health's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin=Net Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-0.719/0.392
=-183.42 %

America Great Health's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=1.113/0.045
=2,473.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 2,473.33% mean?
America Great Health (AAGH) has a Net Margin % of 2,473.33% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on America Great Health and its competitors. According to the industry distribution chart, America Great Health ranks #15 out of 942 companies in the Biotechnology industry, placing it in the top 1.6%.
Is America Great Health's Net Margin % too high?
America Great Health's current Net Margin % is 2,473.33%. Based on the distribution chart, America Great Health ranks #15 out of 942 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does America Great Health's Net Margin % compare to ADTX and PKTX?
According to the Biotechnology industry distribution chart, America Great Health ranks #15 out of 942 companies for Net Margin %. This places America Great Health in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on America Great Health and its competitors. America Great Health's current Net Margin % is 2,473.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current Net Margin % of 2,473.33%. The current Net Margin % is 2,473.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For America Great Health (AAGH), the current Net Margin % is 2,473.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

America Great Health Business Description

Address 1609 W Valley Boulevard, Unit 338A, Alhambra, CA, USA, 91803
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.